Clinical Trial Update: A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

An update on the clinical trial evaluating the PET imaging agent [F-18]HX4 in head and neck cancer patients, noting that Phase 1 and Phase 2 studies have been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• [F-18]HX4

Snippet

Sponsor: Siemens Molecular Imaging | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: WITHDRAWN